The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

DORAXX 25 mg/ml solution for injection for pigs

Dopharma Research B.V.VPA10791/015/001

Main Information

Trade NameDORAXX 25 mg/ml solution for injection for pigs
Active SubstancesTulathromycin
Dosage FormSolution for injection
Licence HolderDopharma Research B.V.
License Holder AddressZalmweg 24
4941 VX Raamsdonksveer
Licence NumberVPA10791/015/001

Group Information

ATC CodeQJ01FA94 tulathromycin
Therapeutic ClassAntibacterial


License statusAuthorised
Licence Issued07/01/2022
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back